IPCA Laboratories posts Q1 FY24 consolidated PAT at Rs. 162.82 Cr

IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023

Granules India posts Q1 FY24 revenue from operations at Rs. 985.5 Cr

API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24

IOL Chemicals and Pharmaceuticals posts Q1 FY24 consolidated PAT at Rs. 45.86 Cr

IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023

SMS Lifesciences India posts Q1 FY24 consolidated loss at Rs. 1.79 Cr

The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023

Hester Biosciences posts Q1 FY24 consolidated PAT at Rs. 5.86 Cr

Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023

Suven Life Sciences posts Q1 FY24 consolidated loss at Rs. 24.09 Cr

Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023

Natural Capsules Q1 FY24 consolidated PAT falls to Rs. 1.82 Cr

Natural Capsules Ltd. has reported total income of Rs. 37.87 crores during the period ended June 30, 2023

Abbott India's Q1 FY24 PAT up at Rs. 290.24 Cr

Abbott India has reported total income of Rs. 1535 crores during the period ended June 30, 2023

Dishman Carbogen Amcis posts Q1 FY24 consolidated PAT at Rs. 17 Cr

Dishman Carbogen Amcis has reported total income of Rs. 729.91 crores during the period ended June 30, 2023

Lincoln Pharmaceuticals posts Q1 FY24 standalone net profit at Rs. 19.01 Cr